{"id":"https://openalex.org/W3082792283","doi":"https://doi.org/10.1158/1557-3265.ovca19-ia26","title":"Abstract IA26: Combined PARP and immune checkpoint inhibition in ovarian cancer","display_name":"Abstract IA26: Combined PARP and immune checkpoint inhibition in ovarian cancer","publication_year":2020,"publication_date":"2020-07-01","ids":{"openalex":"https://openalex.org/W3082792283","doi":"https://doi.org/10.1158/1557-3265.ovca19-ia26","mag":"3082792283"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.ovca19-ia26","doi":"https://doi.org/10.1158/1557-3265.ovca19-ia26","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.ovca19-ia26","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076246054","display_name":"Panagiotis A. Konstantinopoulos","orcid":"https://orcid.org/0000-0002-1032-1479","observed_orcids":["https://orcid.org/0000-0002-1032-1479"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Panagiotis A. Konstantinopoulos","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5076246054"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"13_Supplement","first_page":"IA26","last_page":"IA26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/sting-signaling","display_name":"STING signaling","score":0.7879999876022339},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.9879999756813049},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7680000066757202},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.8059999942779541},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.890999972820282},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.8078672885894775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6190091967582703},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5807914137840271},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5792534947395325},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.539359986782074},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.521557092666626},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4955497980117798},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4647507071495056},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.4239044189453125},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3632817566394806},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33931711316108704},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.26056545972824097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22069883346557617},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16312193870544434},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.ovca19-ia26","doi":"https://doi.org/10.1158/1557-3265.ovca19-ia26","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.ovca19-ia26","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2961683572","https://openalex.org/W4285586350","https://openalex.org/W4392654441","https://openalex.org/W4220735080","https://openalex.org/W7139967933","https://openalex.org/W3137904213","https://openalex.org/W3083650530","https://openalex.org/W3092289147","https://openalex.org/W3094072016","https://openalex.org/W7213310314"],"abstract_inverted_index":{"Abstract":[0],"Ovarian":[1,169],"cancer":[2,157],"(OC)":[3],"is":[4,40,73,103],"one":[5],"of":[6,30,36,93,100,127,142,161],"the":[7,28,34,106,162],"few":[8],"malignancies":[9],"in":[10,44,49,68,96,116,132,155,168],"which":[11],"immunotherapy":[12],"with":[13],"immune":[14,37,76,86,113,152],"checkpoint":[15,38,77,87,114,129,153],"inhibitors":[16,56],"exhibits":[17],"only":[18],"modest":[19],"activity":[20],"and":[21,72,85,112,135,138,151],"currently":[22],"has":[23],"no":[24],"FDA-approved":[25],"indication.":[26],"Therefore,":[27],"development":[29],"strategies":[31],"to":[32,104],"improve":[33],"efficacy":[35],"blockade":[39],"a":[41,69],"high":[42],"priority":[43],"this":[45,101],"disease.":[46],"Recent":[47],"studies":[48],"OC":[50],"models":[51],"have":[52],"demonstrated":[53],"that":[54,66],"PARP":[55,84,111,150],"(PARPi),":[57],"besides":[58],"their":[59],"direct":[60],"cytotoxic":[61],"effects,":[62],"exhibit":[63],"antitumor":[64],"immunity":[65],"occurs":[67],"STING-dependent":[70],"manner":[71],"augmented":[74],"by":[75],"blockade.":[78],"Based":[79],"on":[80,166],"these":[81],"studies,":[82],"combined":[83,110],"inhibition":[88,115,154],"represents":[89],"an":[90],"active":[91],"area":[92],"clinical":[94,125],"investigation":[95],"OC.":[97],"The":[98],"goal":[99],"presentation":[102],"outline":[105],"preclinical":[107],"data":[108],"behind":[109],"OC,":[117],"highlight":[118],"preliminary":[119],"results":[120],"as":[121,123],"well":[122],"ongoing":[124],"trials":[126],"PARPi/immune":[128],"inhibitor":[130],"combinations":[131],"both":[133],"first-line":[134],"recurrent":[136],"disease,":[137],"discuss":[139],"emerging":[140],"biomarkers":[141],"response.":[143],"Citation":[144],"Format:":[145],"Panagiotis":[146],"A.":[147],"Konstantinopoulos.":[148],"Combined":[149],"ovarian":[156],"[abstract].":[158],"In:":[159],"Proceedings":[160],"AACR":[163],"Special":[164],"Conference":[165],"Advances":[167],"Cancer":[170,182],"Research;":[171],"2019":[172],"Sep":[173],"13-16,":[174],"2019;":[175],"Atlanta,":[176],"GA.":[177],"Philadelphia":[178],"(PA):":[179],"AACR;":[180],"Clin":[181],"Res":[183],"2020;26(13_Suppl):Abstract":[184],"nr":[185],"IA26.":[186]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2020-09-08T00:00:00"}